Expression of avian sarcoma virus genes in tumor cells derived from different periods of tumor growthPOULIN, L; WAINBERG, M. A.Microbial pathogenesis. 1987, Vol 2, Num 2, pp 101-112, issn 0882-4010Article

Susceptibility of EBV-carrying B cell lines to infection by HIV-1 : variability of production of progeny virus and expression of viral antigensTREMBLAY, M; WAINBERG, M. A.Cancer letters. 1989, Vol 48, Num 2, pp 95-103, issn 0304-3835, 9 p.Article

Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell linesTREMBLAY, M; WAINBERG, M. A.The Journal of infectious diseases. 1989, Vol 160, Num 1, pp 31-36, issn 0022-1899Article

Direct involvement of extracellular HIV-1 virions in the apoptosis of CD8+ lymphocytes : a two-step modelMERCURE, L; WAINBERG, M. A.Medical hypotheses. 1994, Vol 42, Num 3, pp 159-168, issn 0306-9877Article

Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential seraTREMBLAY, M; WAINBERG, M. A.The Journal of infectious diseases. 1990, Vol 162, Num 3, pp 735-737, issn 0022-1899Article

Public health implications of antiretroviral therapy and HIV drug resistanceWAINBERG, M. A; FRIEDLAND, G.JAMA, the journal of the American Medical Association. 1998, Vol 279, Num 24, pp 1977-1983, issn 0098-7484Article

The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virusBARUCHEL, S; WAINBERG, M. A.Journal of leukocyte biology. 1992, Vol 52, Num 1, pp 111-114, issn 0741-5400Article

Inhibition by AZT of HIV-1 replication in acutely infected U-937 cellsBOULERICE, F; WAINBERG, M. A.Journal of leukocyte biology. 1990, Vol 47, Num 6, pp 498-505, issn 0741-5400, 8 p.Article

Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS)ROY, S; WAINBERG, M. A.Journal of leukocyte biology. 1988, Vol 43, Num 1, pp 91-97, issn 0741-5400Article

Alteration of phenotype of «regressor» avian sarcoma cells following treatment with phorbol ester = Altération du phénotype de cellules de sarcome aviaire «régressantes après un traitement avec l'ester de phorbolWAINBERG, M. A; POULIN, L.Cancer letters. 1983, Vol 19, Num 3, pp 273-282, issn 0304-3835Article

Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcriptionARTS, E. J; WAINBERG, M. A.Advances in virus research. 1996, Vol 46, pp 97-163, issn 0065-3527Article

Immunological responsiveness against tumors induced by avian sarcoma virus: reduced expression of pp60^src kinase activity in regressing tumorsPOULIN, L; GRISE-MIRON, L; WAINBERG, M. A et al.Journal of virology. 1985, Vol 53, Num 3, pp 800-806, issn 0022-538XArticle

Zidovudine-resistant and -sensitive HIV-1 isolates from patients on drug therapy : in vitro studies evaluating level of replication-competent viruses and cytopathogenicityTREMBLAY, M; ROOKE, R; WAINBERG, M. A et al.AIDS (London). 1992, Vol 6, Num 12, pp 1445-1449, issn 0269-9370Article

Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1BOUR, S; BOULERICE, F; WAINBERG, M. A et al.Journal of virology. 1991, Vol 65, Num 12, pp 6387-6396, issn 0022-538XArticle

AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cellsROOKE, R; TREMBLAY, M; WAINBERG, M. A et al.Virology (New York, NY). 1990, Vol 176, Num 1, pp 205-215, issn 0042-6822Article

Presence of insulin binding sites on viral particlesVIVEK SAMNOTRA; GERMINARIO, R. J; WAINBERG, M. A et al.Antiviral research. 1988, Vol 9, Num 5, pp 285-293, issn 0166-3542Article

Immunological responsiveness against tumors induced by avian sarcoma virus: reduced expression of pp60^src kinase activity in regressing tumorsPOULIN, L; GRISE-MIRON, L; WAINBERG, M. A et al.Journal of virology. 1985, Vol 53, Num 3, pp 800-806, issn 0022-538XArticle

Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancerMARGOLESE, R. G; WAINBERG, M. A.Clinical and experimental immunology (Print). 1985, Vol 62, Num 1, pp 85-94, issn 0009-9104Article

Mécanismes de réduction de l'expression des récepteurs CD4 à la surface des cellules infectées par le VIH-1 = Mechanisms of down-modulation of CD4 receptors on the surface of HIV-1 infected cellsGELEZIUNAS, R; MORIN, N; WAINBERG, M. A et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1996, Vol 319, Num 8, pp 653-662, issn 0764-4469Article

Development and significance of nucleoside drug resistance in infection caused by the human immunodeficiency virus type 1SMITH, M; SALOMON, H; WAINBERG, M. A et al.Clinical and investigative medicine. 1994, Vol 17, Num 3, pp 226-243, issn 0147-958XArticle

Pathogenesis and therapy of HIV-1 infection of the central nervous systemGELEZIUNAS, R; SCHIPPER, H. M; WAINBERG, M. A et al.AIDS (London). 1992, Vol 6, Num 12, pp 1411-1426, issn 0269-9370Article

Effect of co-incubation with cytomegalovirus on growth of interleukin 2-dependent lymphocytesNUMAZAKI, K; GOLDMAN, H; WAINBERG, M. A et al.Microbial pathogenesis. 1988, Vol 4, Num 2, pp 137-144, issn 0882-4010Article

Est-il possible qu'il n'y aura jamais de résistance contre le dolutégravir si ce médicament est utilisé en première ligne ? = What if HIV were unable to develop resistance against dolutegravir as first line therapeutic agent?WAINBERG, M. A; MESPLEDE, T; RAFFI, F et al.Journal des anti-infectieux (Print). 2014, Vol 16, Num 2, pp 44-49, issn 2210-6545, 6 p.Article

Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medicationsFRIEDMAN, S. R; WAINBERG, M. A; DRUCKER, E et al.AIDS (London). 1998, Vol 12, Num 16, pp 2089-2093, issn 0269-9370Article

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infectionBOUR, S; GELEZIUNAS, R; WAINBERG, M. A et al.Microbiological reviews. 1995, Vol 59, Num 1, pp 63-93, issn 0146-0749Article